Cargando…
Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19
INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecuti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542440/ https://www.ncbi.nlm.nih.gov/pubmed/34720312 http://dx.doi.org/10.1016/j.eimc.2021.10.005 |
_version_ | 1784589430406774784 |
---|---|
author | Pablo-Marcos, Daniel Abascal, Beatriz Lloret, Lara Gutiérrez Cuadra, Manuel Velasco, Nieves Valero, Carmen |
author_facet | Pablo-Marcos, Daniel Abascal, Beatriz Lloret, Lara Gutiérrez Cuadra, Manuel Velasco, Nieves Valero, Carmen |
author_sort | Pablo-Marcos, Daniel |
collection | PubMed |
description | INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecutive days), 17 with mouth rinses/gargling of hydrogen peroxide, and 40 controls. PCR were repeated at 3, 11 and 17 days. RESULTS: After intervention the viral load (Log 10 copies/ml) remained similar in povidone-iodine (4.3 ± 2.7 copies/ml), hydrogen peroxide (4.6 ± 2.9 copies/ml; p = 0.40) and controls (4.4 ± 3.0 copies/ml). The percentage of patients with a negative result in the second PCR was 27% in povidone-iodine group, 23% in hydrogen peroxide and 32% in controls; in the third PCR, 62%, 54% and 58% respectively; and in the fourth PCR, 81%, 75% and 81%. CONCLUSION: Our results do not support the clinical usefulness of mouth rinses/gargling with povidone-iodine or hydrogen peroxide in patients with COVID-19. |
format | Online Article Text |
id | pubmed-8542440 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85424402021-10-25 Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 Pablo-Marcos, Daniel Abascal, Beatriz Lloret, Lara Gutiérrez Cuadra, Manuel Velasco, Nieves Valero, Carmen Enferm Infecc Microbiol Clin Original Breve INTRODUCTION: Povidone-iodine and hydrogen peroxide could be effective in against SARS-CoV-2. METHODS: A “non-interventional trial” in 88 patients (43 ± 17 yrs, 55% men) with SARS-CoV-2 in nasopharyngeal swabs (RT-PCR). 31 received mouth rinses/gargling with povidone-iodine (every 8 h, two consecutive days), 17 with mouth rinses/gargling of hydrogen peroxide, and 40 controls. PCR were repeated at 3, 11 and 17 days. RESULTS: After intervention the viral load (Log 10 copies/ml) remained similar in povidone-iodine (4.3 ± 2.7 copies/ml), hydrogen peroxide (4.6 ± 2.9 copies/ml; p = 0.40) and controls (4.4 ± 3.0 copies/ml). The percentage of patients with a negative result in the second PCR was 27% in povidone-iodine group, 23% in hydrogen peroxide and 32% in controls; in the third PCR, 62%, 54% and 58% respectively; and in the fourth PCR, 81%, 75% and 81%. CONCLUSION: Our results do not support the clinical usefulness of mouth rinses/gargling with povidone-iodine or hydrogen peroxide in patients with COVID-19. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-03 2021-10-25 /pmc/articles/PMC8542440/ /pubmed/34720312 http://dx.doi.org/10.1016/j.eimc.2021.10.005 Text en © 2021 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Breve Pablo-Marcos, Daniel Abascal, Beatriz Lloret, Lara Gutiérrez Cuadra, Manuel Velasco, Nieves Valero, Carmen Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title | Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title_full | Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title_fullStr | Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title_full_unstemmed | Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title_short | Utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con COVID-19 |
title_sort | utilidad de los enjuagues con povidona yodada y peróxido de hidrógeno en pacientes con covid-19 |
topic | Original Breve |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542440/ https://www.ncbi.nlm.nih.gov/pubmed/34720312 http://dx.doi.org/10.1016/j.eimc.2021.10.005 |
work_keys_str_mv | AT pablomarcosdaniel utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 AT abascalbeatriz utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 AT lloretlara utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 AT gutierrezcuadramanuel utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 AT velasconieves utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 AT valerocarmen utilidaddelosenjuaguesconpovidonayodadayperoxidodehidrogenoenpacientesconcovid19 |